Review article: Is there significant variation in the risk of gastric cancer associated with Helicobacter pylori infection?

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue SUPPL. 1, 1998, Pages 3-7

  Forman, D ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; CANCER RISK; CASE CONTROL STUDY; CONFERENCE PAPER; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGY; HELICOBACTER PYLORI; HEREDITY; HUMAN; METHODOLOGY; POPULATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STOMACH CANCER; VARIANCE;

ENVIRONMENT; EPIDEMIOLOGIC METHODS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PREVALENCE; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0031929342     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1998.00011.x     Document Type: Review

References (40)

1. International Agency for Research on Cancer. Schistosomes, Liver flukes and Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic risks to Humans, No 61. IARC, Lyon; 1994.
2. Huang J-Q, Sridhar S, Chen Y, Hunt R H. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1996; 110: A532 (Abstract).
3. Forman D, Webb P, Parsonnet J. Helicobacter pylori and gastric cancer. Lancet 1994; 343: 243-4.
4. Kikuchi S, Wada O, Nakajima T, et al. Research Group on Prevention of Gastric Carcinoma among Young Adults. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 1995; 75: 2789-93.
5. Karnes W E, Samloff I M, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterol 1991; 101: 167-74.
6. Forman D. The prevalence of Helicobacter pylori infection in gastric cancer. Aliment Pharmacol Ther 1995; 9: 71-6.
7. Hansson L E, Engstrand L, Nyren O, et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098-103.
8. Munoz N. Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence. Cancer Epi Bio Prev 1994; 3: 445-51.
9. Holcombe C. Helicobacter pylori: the African enigma. Gut 1992; 33: 429-31.
10. Forman D, Sitas F, Newell D G, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608-11.
11. Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
12. Lee A. Helicobacter infections in laboratory animals: a model for gastric neoplasias? Ann Med 1995; 27: 575-82.
13. Beales I L P, Davey N J, Pusey C D, Lechler R I, Calam J. Long-term sequelae of Helicobacter pylori gastritis (letter). Lancet 1995; 346: 381-2.
14. Azuma T, Ito Y, Miyaji H, et al. Immunogenetic analysis of the human leukocyte antigen DQA1 locus in patients with duodenal ulcer or chronic atrophic gastritis harbouring Helicobacter pylori. Eur J Gastroent Hepat 1995; 7(Suppl. 1):S71-3.
15. El-Omar E, Penman I, Ardill J E S, McColl K E L. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut 1995; 36: 534-8.
16. McColl K E L, El-Omar E. Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer. Scand J Castro 1996; 31 (Suppl. 215): 32-7.
17. Dixon M. Acid, ulcers and H. pylori. Lancet 1993; 342: 384-5.
18. Blaser M J, Chyou P H, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Research 1995; 55: 562-5.
19. Fuchs C S, Mayer R J. Gastric carcinoma. New Engl J Med 1995; 333: 32-41.
20. Kono S, Hirohata T. Nutrition and stomach cancer. Cancer Causes and Control 1996; 7: 41-55.
21. Hansson L E, Engstrand L, Nyren O, et al. Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma. Gastroenterol 1993; 105: 1098-103.
22. Joosens J V, Hill M J, Elliott P, Stamler R, et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries. Int J Epidemiol 1996; 25: 494-504.
23. Tsugane S, Kabuto M, Imai H, et al. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes and Control 1993; 4: 297-305.
24. Tsugane S, Tei Y, Takahashi T, Watanabe S, Sugano K. Salty food intake and risk of Helicobacter pylori infection. Jpn J Cancer Res 1994; 85: 474-8.
25. Kuipers E J, Pérez-Pérez G I, Meuwissen S G M, Blaser M J. Helicobacter pylori and atrophic gastritis: importance of the cag A status. J Nat Can Instit 1995; 87: 1777-80.
26. Blaser M J, Perez-Perez G I, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Research 1995; 55: 2111-5.
27. Parsonnet J, Friedman G D, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301.
28. Parsonnet J, Replogle M, Yang S, Hiatt R. Seroprevalence of CagA-positive strains among Helicobacter pylori-infected, healthy young adults. J Inf Dis 1997; 175: 1240-2.
29. Perez-Perez G I, Bhat N, Gaensbauer J, Fraser A, et al. Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections. Int J Cancer 1997; 72: 453-6.
30. Webb P M, Forman D, Newell D, Covacci A, et al. An international association between prevalence of infection with CagA positive strains of H. pylori and mortality from gastric cancer. Gut 1996; 39 (Suppl. 2): A1 (Abstract).
31. Mitchell H M, Hazell S L, Li Y Y Hu P J. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996; 91: 1785-8.
32. Maeda S, Ogura K, Yoshida H, Kanai F, et al. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 1997; 41 (Suppl. 1): A28 (Abstract).
33. Forman D, Newell D G, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. Bri Med J 1991; 302: 1302-5.
34. Parsonnet J, Friedman G D, Vandersteen D P, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
35. Nomura A, Stemmermann G N, Chyou P H, Kato I, Pérez-Pérez G I, Blaser M J. Helicobacter pylori and gastric carcinoma among Japanese Americans in Hawaii. New Eng J Med 1991; 325: 1132-6.
36. Webb P M, Yu M C, Forman D, et al. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int J Cancer 1996; 67: 603-7.
37. Lin J T, Wang L Y, Wang J T, Wang T H, Yang C S, Chen C J. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res 1995; 15: 603-6.
38. Hansen S, Vollset S E, Melby K, Jellum E. Strong association of previous Helicobacter pylori infection to distal gastric adenocarcinoma. Am J Gastroenterol 1994; 89: 1358 (Abstract).
39. Aromaa A, Kosunen T U, Knekt P, et al. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen 1 levels are associated with increased risk of gastric cancer. Am J Epidemiol 1996; 144: 142-8.
40. Simán J H, Forsgren A, Florén C-H. Association between Helicobacter pylori and gastric carcinoma in the city of Malmö, Sweden. A prospective study. Gut 1997; 41: A45 (Abstract).